Erratum: Kinetic and mechanistic insight into the thermodynamic degradation of saxagliptin (Journal of Organic Chemistry (2011) 76 (10332) DOI: 10.1021/jo202052a);Kinetic and mechanistic insight into the thermodynamic degradation of saxagliptin

Journal of Organic Chemistry

Volumn 76, Issue 24, 2011, Pages 10332-10337

  Jones, G Scott ^a   Savage, Scott A ^a   Ivy, Sabrina ^a   Benitez, Patrick L ^a,b   Ramirez, Antonio ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMISTRY; ORGANIC COMPOUNDS;

AUTOCATALYTIC; DIPEPTIDYL PEPTIDASE IV; KINETICS AND MECHANISM; SOLVENT EFFECTS; TRACE LEVEL; TRANSITION STRUCTURES;

SOLVENTS;

4 (3 HYDROXYADAMANTAN 1 YL) 6 IMINOHEXAHYDRO 1H CYCLOPROPA[4,5]PYRROLO[1,2 A]PYRAZIN 3(1AH) ONE; AMIDINE; PIPERAZINEDIONE; SAXAGLIPTIN; SOLVENT; UNCLASSIFIED DRUG; WATER;

ARTICLE; CATALYSIS; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; CYCLIZATION; DRUG DEGRADATION; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; EPIMERIZATION; HYDROLYSIS; PROCESS DEVELOPMENT; PROTON TRANSPORT; SOLVENT EFFECT; THERMODYNAMICS;

EID: 84055193760     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo400544x     Document Type: Erratum

References (14)

1. FDA News Release: FDA Approves New Drug Treatment for Type 2 Diabetes. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm174780.htm (July 31, 2009).
2. Havale, S. H.; Manojit, P. Bioorg. Med. Chem. 2009, 17, 1783.
3. Magnin, D. R.; Robl, J. A.; Sulsky, R. B.; Augeri, D. J.; Huang, Y.; Simpkins, L. M.; Taunk, P. C.; Betebenner, D. A.; Robertson, J. G.; Abboa-Offei, B. E.; Wang, A.; Cap, M.; Xin, L; Tao, L.; Sitkoff, D. F.; Malley, M. F.; Gougoutas, J. Z.; Khanna, A.; Huang, Q.; Han, S.-P.; Parker, R. A.; Hamann, L. G. J. Med. Chem. 2004, 47, 2587.
4. Fura, A.; Khanna, A.; Vyas, V.; Koplowitz, B.; Chang, S.-Y.; Caporuscio, C.; Boulton, D. W.; Christopher, L. J.; Chadwick, K. D.; Hamann, L. G.; Humphreys, W. G.; Kirby, M. Drug Metab. Dispos. 2009, 37, 1164.
5. Savage, S. A.; Jones, G. S.; Kolotuchin, S.; Ramrattan, S. A.; Vu, T.; Waltermire, R. E. Org. Process Res. Dev. 2009, 13, 1169.
6. Marcus, Y. The Properties of Solvents; John Wiley & Sons: Chichester, U. K., 1998; Wiley Series in Solution Chemistry Vol. 4.
7. see: Venkatasubban, K. S.; Schowen, R. L. Crit. Rev. Biochem. 1984, 17, 1.
8. Schowen, K. B. J. In Transition States of Biochemical Processes; Gandour, R. D., Schowen, R. L., Eds.; Plenum Press: New York, 1978.
9. see: Continuum Solvation Models in Chemical Physics: From Theory to Applications; Tomasi, J., Mennucci, B., Cammi, R, Eds.; Wiley: Chichester, U. K., 2007.
10. Swain, C. G.; Brown, J. F. Jr. J. Am. Chem. Soc. 1952, 74, 2538.
11. Field, M. J.; Hillier, I. H. J. Chem. Soc., Perkin Trans. 2 1987, 617.
12. (a) Chen, Y.; Gai, F.; Petrich, J. W. J. Am. Chem. Soc. 1993, 115, 10158.
13. (b) Boyle, P. H.; Convery, M. A.; Davis, A. P.; Hosken, G. D.; Murray, B. A. J. Chem. Soc. Chem. Commun. 1992, 239.
14. Bordwell, F. G. Acc. Chem. Res. 1988, 21, 456.